Coronavirus
Germany’s Biotech Boom
The coronavirus pandemic has given German biotechnology companies a massive boom. What does the state of the industry look like two years after the start of the crisis?
Biotech and pharma companies in Germany were among the first to develop vaccines and diagnostics against Covid-19 at the outset of the pandemic. The biotechnology industry received more public attention than ever after these breakthroughs, with private investment in the sector reaching record levels.
